EUVIMEDEUVIMED entdecken
Open Access

Gut Microbiota−Tryptophan Metabolism−GLP-1 Axis Participates in β-Cell Regeneration Induced by Dapagliflozin

Yafei Jiang, Jin Yang, Li Xia, Tianjiao Wei, Xiaona Cui, Dandan Wang, Zirun Jin, Xiafang Lin, Fei Li, Kun Yang, Shan Lang, Ye Liu und 4 weitere

Diabetes · 01.06.2024 · 73 (6) · 926-940

DOI: 10.2337/db23-0553 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diabetes, online erschienen am 12.03.2024. Verfasst von Yafei Jiang und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology and Metabolism, State Key Laboratory of Female Fertility Promotion, Peking University Third Hospital, Beijing, China. Hauptthemen laut MEDLINE: Benzhydryl Compounds, Insulin-Secreting Cells, Glucagon-Like Peptide 1, Gastrointestinal Microbiome. Die Arbeit wurde bisher 45-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Talent Project of Clinical Key Project of Peking University Third Hospital, National Natural Science Foundation of China, the National Clinical Key Specialty Construction Program, P. R. China (2023).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Sodium–glucose cotransporter 2 inhibitors, efficacious antidiabetic agents that have cardiovascular and renal benefits, can promote pancreatic β-cell regeneration in type 2 diabetic mice. However, the underlying mechanism remains unclear. In this study, we aimed to use multiomics to identify the mediators involved in β-cell regeneration induced by dapagliflozin. We showed that dapagliflozin lowered blood glucose level, upregulated plasma insulin level, and increased islet area in db/db mice. Dapagliflozin reshaped gut microbiota and modulated microbiotic and plasmatic metabolites related to tryptophan metabolism, especially l-tryptophan, in the diabetic mice. Notably, l-tryptophan upregulated the mRNA level of glucagon-like peptide 1 (GLP-1) production–related gene (Gcg and Pcsk1) expression and promoted GLP-1 secretion in cultured mouse intestinal L cells, and it increased the supernatant insulin level in primary human islets, which was eliminated by GPR142 antagonist. Transplant of fecal microbiota from dapagliflozin-treated mice, supplementation of l-tryptophan, or treatment with dapagliflozin upregulated l-tryptophan, GLP-1, and insulin or C-peptide levels and promoted β-cell regeneration in db/db mice. Addition of exendin 9-39, a GLP-1 receptor (GLP-1R) antagonist, or pancreatic Glp1r knockout diminished these beneficial effects. In summary, treatment with dapagliflozin in type 2 diabetic mice promotes β-cell regeneration by upregulating GLP-1 production, which is mediated via gut microbiota and tryptophan metabolism. Article Highlights

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Benzhydryl CompoundsInsulin-Secreting CellsGlucagon-Like Peptide 1Gastrointestinal MicrobiomeTryptophanGlucosidesRegenerationAnimalsMiceHumansMaleInsulinBlood GlucoseDiabetes Mellitus, Type 2Mice, Inbred C57BLSodium-Glucose Transporter 2 InhibitorsDiabetes Mellitus, ExperimentalGlucagon-Like Peptide-1 Receptor

Substanzen

Benzhydryl CompoundsGlucagon-Like Peptide 1TryptophanGlucosidesInsulinBlood GlucoseSodium-Glucose Transporter 2 InhibitorsGlucagon-Like Peptide-1 Receptordapagliflozin

Autor:innen und Institutionen

  • Department of Endocrinology and Metabolism, State Key Laboratory of Female Fertility Promotion, Peking University Third Hospital, Beijing, China.
  • Clinical Stem Cell Research Center, Peking University Third Hospital, Beijing, China.
  • Department of Urology, Peking University Third Hospital, Beijing, China.
  • Center for Reproductive Medicine, Peking University Third Hospital, Beijing, China.
  • Department of Obstetrics and Gynecology, Peking University Third Hospital, Beijing, China.

ORCID-Profile: Tianpei Hong, Rui Wei

Förderung

  • Talent Project of Clinical Key Project of Peking University Third Hospital
  • National Natural Science Foundation of China
  • the National Clinical Key Specialty Construction Program, P. R. China (2023)
  • Clinical Medicine Plus X-Young Scholars Project of Peking University
  • Beijing Municipal Natural Science Foundation
  • Tianjin Municipal Human Resources and Social Security Bureau

Zitieren

APA

Jiang, Y., Yang, J., Xia, L., Wei, T., Cui, X., Wang, D., Jin, Z., Lin, X., Li, F., Yang, K., Lang, S., Liu, Y., Hang, J., Zhang, Z., Hong, T., & Wei, R. (2024). Gut Microbiota−Tryptophan Metabolism−GLP-1 Axis Participates in β-Cell Regeneration Induced by Dapagliflozin. Diabetes, 73(6), 926-940. https://doi.org/10.2337/db23-0553

Vancouver

Jiang Y, Yang J, Xia L, Wei T, Cui X, Wang D, et al. Gut Microbiota−Tryptophan Metabolism−GLP-1 Axis Participates in β-Cell Regeneration Induced by Dapagliflozin. Diabetes. 2024;73(6):926-940. doi:10.2337/db23-0553

BibTeX
@article{Jiang2024,
  author = {Jiang, Yafei and Yang, Jin and Xia, Li and Wei, Tianjiao and Cui, Xiaona and Wang, Dandan and Jin, Zirun and Lin, Xiafang and Li, Fei and Yang, Kun and Lang, Shan and Liu, Ye and Hang, Jing and Zhang, Zhe and Hong, Tianpei and Wei, Rui},
  title = {Gut Microbiota−Tryptophan Metabolism−GLP-1 Axis Participates in β-Cell Regeneration Induced by Dapagliflozin},
  journal = {Diabetes},
  year = {2024},
  volume = {73},
  number = {6},
  pages = {926--940},
  doi = {10.2337/db23-0553}
}
Kostenlos starten →